
|Articles|September 1, 2002
Up to 40% of cancers may not present clinically
Author(s)Scott Tennant
Seattle-Despite the way it was portrayed in some of the lay media, the authors of a recent study on the "overdiagnosis" of prostate cancer insist their work should not be construed as hostile to the practice of PSA screening. In fact, says one investigator, results of the study paint an overall favorable picture of screening.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
From OR to office: How Break Wave changes urology practice workflow
2
Published VAPOR 2 data evaluate water vapor ablation for localized prostate cancer
3
Matthew Truesdale, MD, on IsoPSA performance with and without mpMRI
4
HoLEP patient selection and the technical error most surgeons make past training
5












